News for Clover Corporation Limited (CLV.AX)

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.76% to 6,987.60.

Omega-3, lipids, and fatty acid B2B company Clover Corporation delivers healthy results for its first half of fiscal 2023, with sales up 49.5% and NPAT surging 81.1%.

The Clover Corporation Limited (ASX:CLV) share price has risen after the ASX share revealed large profit growth in its HY23 result.

ASX dairy stocks have fallen ~31% on average over 2022, but farmers are happy. And farmers are NEVER happy.

Clover can improve the IQ of children born prematurely and First Graphene nabs a US patent for its novel supercapacitor technology

Read Toni Brendish Acquires 9,900 Shares of Clover Co. Limited (ASX:CLV) Stock at ETF Daily News

Read Clover Co. Limited (CLV) to Issue Interim Dividend of $0.01 on April 27th at ETF Daily News

Clover Corporation (ASX:CLV) has released new results from its clinical research study called the N3RO trial, showing that Clover's proprietary emulsion high DHA improved cognitive development.

Investors who were holding shares in Cuba-based oil player Melbana Energy (ASX:MAY) to start the year are now sitting on a 7-bagger.